Order Article Reprints

Bogdanet D, Toth Castillo M, Doheny H, Dervan L, Luque-Fernandez M-A, Halperin JA, O’Shea PM, Dunne FP. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland. Journal of Clinical Medicine. 2022; 11(13):3895. https://doi.org/10.3390/jcm11133895

Bogdanet, Delia, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel-Angel Luque-Fernandez, Jose A. Halperin, Paula M. O’Shea, and Fidelma P. Dunne. 2022. "The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland" Journal of Clinical Medicine 11, no. 13: 3895. https://doi.org/10.3390/jcm11133895

Bogdanet, D., Toth Castillo, M., Doheny, H., Dervan, L., Luque-Fernandez, M.-A., Halperin, J. A., O’Shea, P. M., & Dunne, F. P. (2022). The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland. Journal of Clinical Medicine, 11(13), 3895. https://doi.org/10.3390/jcm11133895